We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGIO icon
1026
Agios Pharmaceuticals
AGIO
$2.14B
$14K ﹤0.01%
386
BLUE
1027
DELISTED
bluebird bio
BLUE
$14K ﹤0.01%
24
EWW icon
1028
iShares MSCI Mexico ETF
EWW
$1.94B
$14K ﹤0.01%
500
GRFS
1029
Grifois
GRFS
$5.4B
$14K ﹤0.01%
711
HALO icon
1030
Halozyme
HALO
$9.9B
$14K ﹤0.01%
769
RARE icon
1031
Ultragenyx Pharmaceutical
RARE
$2.51B
$14K ﹤0.01%
326
MNDT
1032
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
$14K ﹤0.01%
+503
New +$5.83K
ALLO icon
1033
Allogene Therapeutics
ALLO
$566M
$13K ﹤0.01%
688
BRT
1034
BRT Apartments
BRT
$280M
$13K ﹤0.01%
1,300
FOLD
1035
DELISTED
Amicus Therapeutics
FOLD
$13K ﹤0.01%
1,438
ZLAB icon
1036
Zai Lab
ZLAB
$2.11B
$13K ﹤0.01%
250
CCXI
1037
DELISTED
ChemoCentryx, Inc.
CCXI
$13K ﹤0.01%
329
ALLK
1038
DELISTED
Allakos
ALLK
$12K ﹤0.01%
275
KOD icon
1039
Kodiak Sciences
KOD
$2.57B
$12K ﹤0.01%
246
TLK icon
1040
Telkom Indonesia
TLK
$14.3B
$12K ﹤0.01%
630
DCPH
1041
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12K ﹤0.01%
302
ICPT
1042
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
185
ARNA
1043
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12K ﹤0.01%
283
MYOK
1044
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$12K ﹤0.01%
261
ALEC icon
1045
Alector
ALEC
$167M
$11K ﹤0.01%
438
APLS
1046
DELISTED
Apellis Pharmaceuticals
APLS
$11K ﹤0.01%
419
AXSM icon
1047
Axsome Therapeutics
AXSM
$12.2B
$11K ﹤0.01%
195
KRTX
1048
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$11K ﹤0.01%
147
PRNB
1049
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$11K ﹤0.01%
185
DNLI icon
1050
Denali Therapeutics
DNLI
$3.74B
$10K ﹤0.01%
587

Similar funds

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.